The immune cell fraction was similar in progressing DCIS and non-progressing DCIS, but higher in Basal and HER2 DCIS subtypes, which was also reflected in Methylation Cluster 1, which predominated the hormone negative DCIS samples. This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.